HHHongbin He

Hongbin He

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hongbin He has a total of 46 co-authors. Here are the top co-authors by number of shared publications:

  • Hongmei Wang

    5 shared publications
  • Hongjun Yang

    Dairy Cattle Research Center, Shandong Academy of Agricultural Sciences, Jinan, People's Republic of China

    3 shared publications
  • Jianming Wu

    Dairy Cattle Research Center, Shandong Academy of Agricultural Sciences, Jinan 250100, PR China

    3 shared publications
  • Guimin Zhao

    2 shared publications
  • Jifeng Zhong

    Dairy Cattle Research Center, Shandong Academy of Agricultural Sciences, Jinan, People's Republic of China

    2 shared publications
  • Li Yu

    Division of Livestock Infectious Diseases, State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Harbin 150001, PR China

    2 shared publications

Latest Publications

    • 1 September 2015
      • Vol. 31  (5) , 488-93

    [Establishment and Preliminary Application of the SYBR Green I Real-time PCR Assay for Detection of the Bovine Enterovirus].

    by Tong Zhu, Guimin Zhao, Furao Shen, Hongmei Wang, Jie Li, Hongbin He

    The bovine enterovirus (BEV) is a pathogen found the digestive tracts of cattle. Recently, the BEV was discovered in cattle in a province in China. A rapid and effective detection method for the BEV is essential. An assay was carried out using two specific primers designed to amplify a highly conserved sequence of the 3D gene. A recombinant plasmid containing the target gene 3D was constructed as a standard control. The limit of detection of the reaction was 7.13 x 10(1) plasmid copies/μL of initial templates, which was tenfold more sensitive than the conventional reverse-transcription-polymerase chain reaction (RT-PCR). Moreover, the assay was highly specific because all negative controls and other viruses of clinical relevance did not develop positive results. Assay performance on field samples was evaluated on 44 (41 diarrhea and 3 aerosol) samples and compared with the conventional RT-PCR assay. Sixteen diarrhea samples were positive (16/41, 39. 02%) and 3 aerosol samples were positive (3/3, 100%). Preliminary results for clinical detection showed that the SYBR Green I real-time PCR assay was highly sensitive, specific and reproducible. The robustness and high-throughput performance of the developed assay make it a powerful tool in diagnostic applications for epidemics and in BEV research.

  • Bovine fetal epithelium cells expressing shRNA targeting viral VP1 gene resisted against foot-and-mouth disease virus

    by Hongmei Wang, Xiao Liu, Jianming Wu, Gang Wu, Li Yu, Chenqiang He, Huiting Yang, Weixin Xie, Xianzhu Xia, Hongbin He


    • 1 February 2013
      • Vol. 29  (2) , 174-7

    [Expression and antiserum preparation of recombinant human antithrombin-III].

    by Shu Bu, Hongmei Wang, Tao Sun, Wenhao Liu, Liqun Wang, Hongbin He

    To express recombinant antithrombin-III (AT-III) in an E.coli expression system, prepare the antiserum of AT-III and determine its titer. Gene segment of AT-III was acquired by cloning technology. Then prokaryotic expression plasmid pET32a(+)-AT-III was constructed and transformed into E.coli competent cells BL21. The cells were induced by IPTG to express AT-III. After purified, the product was used to immunize New Zealand rabbits. Then antiserum was detected using indirect ELISA and Western blotting. Specific bands appeared at about M(r); 77 000, indicating prokaryotic expression protein detected by SDS-PAGE and Western blotting. From the rabbits immunized by the purified fusion protein, we aquired AT-III antiserum, of which the highest titer was 1:12 800 as shown by indirect ELISA. Western blotting showed the antiserum had the ability of specific binding to AT-III protein expressed by 293T and CHO or purified AT-III protein. Antiserum of human AT-III has been prepared successfully.

  • Open Access

    Identification of Short Hairpin RNA Targeting Foot-And-Mouth Disease Virus with Transgenic Bovine Fetal Epithelium Cells

    by Hongmei Wang, Jianming Wu, Xiao Liu, Hongbin He, Fangrong Ding, Hongjun Yang, Lei Cheng, Wenhao Liu, Jifeng Zhong, Yunping Dai, et al.

    Although it is known that RNA interference (RNAi) targeting viral genes protects experimental animals, such as mice, from the challenge of Foot-and-mouth disease virus (FMDV), it has not been previously investigated whether shRNAs targeting FMDV in transgenic dairy cattle or primary transgenic bovine epithelium cells will confer resistance against FMDV challenge. Here we constructed three recombinant lentiviral vectors containing shRNA against VP2 (RNAi-VP2), VP3 (RNAi-VP3), or VP4 (RNAi-VP4) of FMDV, and found that all of them strongly suppressed the transient expression of a FLAG-tagged viral gene fusion protein in 293T cells. In BHK-21 cells, RNAi-VP4 was found to be more potent in inhibition of viral replication than the others with over 98% inhibition of viral replication. Therefore, recombinant lentiviral vector RNAi-VP4 was transfected into bovine fetal fibroblast cells to generate transgenic nuclear donor cells. With subsequent somatic cell cloning, we generated forty transgenic blastocysts, and then transferred them to 20 synchronized recipient cows. Three transgenic bovine fetuses were obtained after pregnant period of 4 months, and integration into chromosome in cloned fetuses was confirmed by Southern hybridization. The primary tongue epithelium cells of transgenic fetuses were isolated and inoculated with 100 TCID50 of FMDV, and it was observed that shRNA significantly suppressed viral RNA synthesis and inhibited over 91% of viral replication after inoculation of FMDV for 48 h. RNAi-VP4 targeting viral VP4 gene appears to prevent primary epithelium cells of transgenic bovine fetus from FMDV infection, and it could be a candidate shRNA used for cultivation of transgenic cattle against FMDV.


    • 1 May 2010
      • Vol. 26  (3) , 244-8

    [ShRNA against NSP4 gene inhibits the proliferation of bovine rotavirus in vitro].

    by Fang-Yuan Chen, Hong-Mei Wang, Shao-Hua Yang, Jian-Ming Wu, Yun-Dong Gao, Xiao Liu, Hong-Jun Yang, Chang-Fa Wang, Ji-Feng Zhong, Li-Qun Wang, et al.

    Based on the NSP4 sequence of bovine rotavirus (BRV), the shRNA was designed and synthesized, and a shRNA recombinant lenti-virus vector RNAi-H1-89 was constructed. The recombinant RNAi-H1-89 Lenti-virus was packaged by transfecting the 293T cell with the recombinant vector RNAi-H1-89 and two helper plasmids using lipofectamine, and then used to infect MA104 cells. The MA104 cells were further infected with BRV strain G6 24h post-infection, with the LacZ shRNA recombinant lenti-virus as control. Thirty-six hours later, the CPE of the infected cells was observed under microscope, shRNA of NSP4 gene inhibited CPE in MA104 cell; the shRNA against NSP4 gene also inhibited NSP4 gene expression by RT-PCR, The virus titer in the cell culture supernatant was significant lower compared with the control group. The above results showed that RNAi-H1-89 against NSP4 gene could specifically silence NSP4 gene expression, and inhibit the proliferation of BRV.

  • Molecular analysis and recombinant expression of bovine neutrophil β-defensin 12 and its antimicrobial activity

    by Jianming Wu, Changfa Wang, Hongbin He, Guixue Hu, Hongjun Yang, Yundong Gao, Jifeng Zhong

    To analyze molecular characteristics and antimicrobial activity of bovine neutrophil β-defensin 12 (BNBD12), Pro-BNBD12 gene was amplified from Chinese Holstein cow using reverse transcription polymerase chain reaction. Based on the sequence of mature BNBD12 and codon preference in E. coli, a modified mature BNBD12 cDNA was synthesized, cloned into pET32a (+) vector and expressed in E. coli BL21 as a 26 kD fusion protein after isopropyl β-d-1-thiogalactopyranoside induction. The expressed mature BNBD12 accounted for 21.4% of total protein. 0.05 mg/ml purified BNBD12 had antimicrobial activity against both E. coli and S. aureus in vitro assayed by agar diffusion method. Electron microscopy found that BNBD12 treatment of E. coli and S. aureus could induce cell content leakage. Taking together, BNBD12 protein was successfully expressed in E. coli and it has antimicrobial activity against both Gram-positive and negative bacteria and potentials in control of mastitis clinically.


    • 1 February 2009
      • Vol. 25  (2) , 176-80

    [Activity and quality comparison of the engineered protein Staphylococcus aureus alpha-hemolysin purified with gel filtration chromatography and Ni-NTA].

    by Haiyan Zhang, Hongjun Yang, Changfa Wang, HongBin He, Weiming Ma, Shaohua Yang

    The alpha-hemolysin protein of Staphylococcus aureus, which was expressed in Escherichia coli BL21 (DE3) with recombinant pET32a(+)-alpha-HL plasmid, was purified with gel filtration chromatography (GFC) and Ni-NTA spin columns. The quality and biological characteristic were compared. First, the purified products were analyzed with SDS-PAGE, and the expected protein band was with a molecular mass of 53 kD. Second, protein concentration was determined by the method of Bradford, and the median hemolytic dose potency (HD50) was finally analyzed with rabbit erythrocyte. The protein purified with GFC was 0.337 mg/mL, its hemolysis activity was 1519 HU/mg, and hemolysin yield was 14.04%. Meanwhile, the protein purified with the Ni-NTA Spin Columns was 0.35 mg/mL, its hemolysis activity was 1463 HU/mg, and hemolysin yield was 17.5%, respectively. The results showed that there is no significant difference in the quality, hemolysis activity and yield of the recombinant proteins purified with Ni-NTA spin columns and GFC.